Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle maturation (GO:0016188) | 5.32494349 |
2 | locomotory exploration behavior (GO:0035641) | 4.61406381 |
3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.50840846 |
4 | L-amino acid import (GO:0043092) | 4.50102950 |
5 | cellular potassium ion homeostasis (GO:0030007) | 4.33048700 |
6 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.26452779 |
7 | sodium ion export (GO:0071436) | 4.25350903 |
8 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.18380157 |
9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.16041275 |
10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.11207533 |
11 | glutamate secretion (GO:0014047) | 4.09845439 |
12 | gamma-aminobutyric acid transport (GO:0015812) | 3.94269819 |
13 | synaptic vesicle exocytosis (GO:0016079) | 3.87480700 |
14 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.81502200 |
15 | axon ensheathment in central nervous system (GO:0032291) | 3.80434590 |
16 | central nervous system myelination (GO:0022010) | 3.80434590 |
17 | regulation of beta-amyloid formation (GO:1902003) | 3.80069335 |
18 | glycine transport (GO:0015816) | 3.70377489 |
19 | potassium ion import (GO:0010107) | 3.68571013 |
20 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.65827005 |
21 | cerebellar granule cell differentiation (GO:0021707) | 3.58742984 |
22 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.57581828 |
23 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.57185640 |
24 | vocalization behavior (GO:0071625) | 3.57023374 |
25 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.54146432 |
26 | neurotransmitter secretion (GO:0007269) | 3.54009528 |
27 | neuronal action potential propagation (GO:0019227) | 3.46971010 |
28 | amino acid import (GO:0043090) | 3.44319792 |
29 | layer formation in cerebral cortex (GO:0021819) | 3.39740889 |
30 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.39610609 |
31 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.31519715 |
32 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.30555777 |
33 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.28944863 |
34 | regulation of synapse structural plasticity (GO:0051823) | 3.28217924 |
35 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.24391406 |
36 | regulation of synaptic vesicle transport (GO:1902803) | 3.21358604 |
37 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.20020635 |
38 | potassium ion homeostasis (GO:0055075) | 3.19984227 |
39 | cellular sodium ion homeostasis (GO:0006883) | 3.17442691 |
40 | negative regulation of inclusion body assembly (GO:0090084) | 3.08655363 |
41 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.07637487 |
42 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.05734348 |
43 | response to thyroid hormone (GO:0097066) | 3.05419989 |
44 | positive regulation of macrophage cytokine production (GO:0060907) | 3.01977845 |
45 | dendritic spine morphogenesis (GO:0060997) | 3.01169168 |
46 | cell communication by electrical coupling (GO:0010644) | 2.99680853 |
47 | exploration behavior (GO:0035640) | 2.99391796 |
48 | neuromuscular process controlling balance (GO:0050885) | 2.99150987 |
49 | neuromuscular process controlling posture (GO:0050884) | 2.99149617 |
50 | activation of protein kinase A activity (GO:0034199) | 2.97085746 |
51 | C4-dicarboxylate transport (GO:0015740) | 2.96778391 |
52 | long-term memory (GO:0007616) | 2.96241713 |
53 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.95826223 |
54 | detection of molecule of bacterial origin (GO:0032490) | 2.92441354 |
55 | regulation of ARF protein signal transduction (GO:0032012) | 2.90146782 |
56 | * neurotransmitter transport (GO:0006836) | 2.89150809 |
57 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.87344336 |
58 | regulation of cellular amide metabolic process (GO:0034248) | 2.86982298 |
59 | adenosine receptor signaling pathway (GO:0001973) | 2.84049436 |
60 | protein localization to synapse (GO:0035418) | 2.83442931 |
61 | alanine transport (GO:0032328) | 2.80920511 |
62 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.79516670 |
63 | response to auditory stimulus (GO:0010996) | 2.78577651 |
64 | alpha-linolenic acid metabolic process (GO:0036109) | 2.77090971 |
65 | * regulation of neurotransmitter levels (GO:0001505) | 2.76517779 |
66 | regulation of inclusion body assembly (GO:0090083) | 2.74196757 |
67 | proline transport (GO:0015824) | 2.73730868 |
68 | synaptic transmission, glutamatergic (GO:0035249) | 2.70823839 |
69 | acidic amino acid transport (GO:0015800) | 2.69403998 |
70 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.69179045 |
71 | one-carbon compound transport (GO:0019755) | 2.67458148 |
72 | L-glutamate transport (GO:0015813) | 2.66774817 |
73 | regulation of synaptic plasticity (GO:0048167) | 2.66361259 |
74 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.64163329 |
75 | positive regulation of membrane potential (GO:0045838) | 2.63588191 |
76 | nerve growth factor signaling pathway (GO:0038180) | 2.63020760 |
77 | auditory behavior (GO:0031223) | 2.62030719 |
78 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.62004819 |
79 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.61808898 |
80 | glutamate receptor signaling pathway (GO:0007215) | 2.61382042 |
81 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.60092227 |
82 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.58915205 |
83 | L-phenylalanine catabolic process (GO:0006559) | 2.58810888 |
84 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.58810888 |
85 | dendrite morphogenesis (GO:0048813) | 2.57328422 |
86 | gas transport (GO:0015669) | 2.57121618 |
87 | neuron-neuron synaptic transmission (GO:0007270) | 2.56039037 |
88 | macrophage activation involved in immune response (GO:0002281) | 2.56034224 |
89 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.53047069 |
90 | macrophage activation (GO:0042116) | 2.52072671 |
91 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.51637618 |
92 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.51448824 |
93 | prepulse inhibition (GO:0060134) | 2.51112300 |
94 | regulation of macrophage cytokine production (GO:0010935) | 2.50976321 |
95 | neuronal ion channel clustering (GO:0045161) | 2.50792449 |
96 | response to peptidoglycan (GO:0032494) | 2.50309516 |
97 | positive regulation of dendritic spine development (GO:0060999) | 2.49528028 |
98 | positive regulation of Rap GTPase activity (GO:0032854) | 2.49399080 |
99 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.49285281 |
100 | regulation of regulated secretory pathway (GO:1903305) | 2.49197481 |
101 | actin filament polymerization (GO:0030041) | 2.48609067 |
102 | transmission of nerve impulse (GO:0019226) | 2.48289607 |
103 | membrane hyperpolarization (GO:0060081) | 2.47528183 |
104 | regulation of postsynaptic membrane potential (GO:0060078) | 2.46988705 |
105 | * neurotransmitter uptake (GO:0001504) | 2.45506941 |
106 | import into cell (GO:0098657) | 2.45040755 |
107 | positive regulation of synapse maturation (GO:0090129) | 2.44783700 |
108 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.44593198 |
109 | regulation of leukocyte degranulation (GO:0043300) | 2.43769187 |
110 | adult walking behavior (GO:0007628) | 2.43700630 |
111 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.43556730 |
112 | positive regulation of mast cell degranulation (GO:0043306) | 2.43556730 |
113 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.43379341 |
114 | cell volume homeostasis (GO:0006884) | 2.43306749 |
115 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.42924346 |
116 | microglial cell activation (GO:0001774) | 2.42869001 |
117 | long-term synaptic potentiation (GO:0060291) | 2.42503225 |
118 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.42435286 |
119 | response to manganese ion (GO:0010042) | 2.41609433 |
120 | myelin maintenance (GO:0043217) | 2.41346368 |
121 | cellular extravasation (GO:0045123) | 2.40523818 |
122 | regulation of mast cell degranulation (GO:0043304) | 2.39507556 |
123 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.39062278 |
124 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.38273636 |
125 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.37662131 |
126 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.37544690 |
127 | L-phenylalanine metabolic process (GO:0006558) | 2.37544690 |
128 | membrane repolarization (GO:0086009) | 2.37219474 |
129 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.37182119 |
130 | regulation of macrophage chemotaxis (GO:0010758) | 2.36636405 |
131 | regulation of ARF GTPase activity (GO:0032312) | 2.36428419 |
132 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.35557696 |
133 | positive regulation of cholesterol efflux (GO:0010875) | 2.35392846 |
134 | positive regulation of potassium ion transport (GO:0043268) | 2.35326477 |
135 | regulation of neurotransmitter secretion (GO:0046928) | 2.35138508 |
136 | neuron cell-cell adhesion (GO:0007158) | 2.33247791 |
137 | cerebellar Purkinje cell layer development (GO:0021680) | 2.32838098 |
138 | apoptotic cell clearance (GO:0043277) | 2.32304154 |
139 | neuromuscular process (GO:0050905) | 2.32241553 |
140 | response to methylmercury (GO:0051597) | 2.32164385 |
141 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.30114796 |
142 | modulation by symbiont of host immune response (GO:0052553) | 2.30114796 |
143 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.29322396 |
144 | mating behavior (GO:0007617) | 2.28827898 |
145 | vesicle transport along microtubule (GO:0047496) | 2.28330355 |
146 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.28190889 |
147 | * positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.28040181 |
148 | regulation of neurotransmitter transport (GO:0051588) | 2.27466180 |
149 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.27320583 |
150 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.27064009 |
151 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.25986230 |
152 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.24882042 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.89258099 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.88018053 |
3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59932222 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.52551950 |
5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.43340652 |
6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.37707934 |
7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.37707934 |
8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.32532661 |
9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.28859339 |
10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.27825907 |
11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.24189108 |
12 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.17273755 |
13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.14739310 |
14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14118451 |
15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.12528932 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.10996338 |
17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.10465624 |
18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.10428560 |
19 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.10420073 |
20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.08542842 |
21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.07801554 |
22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.05589357 |
23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.98533478 |
24 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93403603 |
25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.91419609 |
26 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85511835 |
27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83402820 |
28 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.82378729 |
29 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.81813587 |
30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.78613132 |
31 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.78321349 |
32 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.75347465 |
33 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.74487782 |
34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72997124 |
35 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.72790051 |
36 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.72733995 |
37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.71028217 |
38 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70656102 |
39 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.70090276 |
40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.69163232 |
41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.62765722 |
42 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.58948312 |
43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.57189264 |
44 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.54313430 |
45 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.51799924 |
46 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.48293645 |
47 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48155115 |
48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45392945 |
49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39945532 |
50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39133921 |
51 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.39001804 |
52 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38482289 |
53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36888174 |
54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.33661729 |
55 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.33424083 |
56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32776160 |
57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31584975 |
58 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.31271809 |
59 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30697751 |
60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30689989 |
61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29739054 |
62 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.29192688 |
63 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.24074246 |
64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23634443 |
65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22134205 |
66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.21761552 |
67 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.21480174 |
68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20703799 |
69 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17660156 |
70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17562376 |
71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17323693 |
72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12481382 |
73 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.11653774 |
74 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11230996 |
75 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.11188649 |
76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10775837 |
77 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.10633930 |
78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10256167 |
79 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.10246258 |
80 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09766634 |
81 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09357652 |
82 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09297932 |
83 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.08692448 |
84 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08599951 |
85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06780524 |
86 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.06455095 |
87 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05939245 |
88 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05401221 |
89 | * AR_19668381_ChIP-Seq_PC3_Human | 1.04587671 |
90 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04311531 |
91 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03685644 |
92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02797444 |
93 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02419573 |
94 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.02119039 |
95 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02096903 |
96 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01515317 |
97 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01515317 |
98 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00874054 |
99 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.00626649 |
100 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.00309150 |
101 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.00174467 |
102 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99008620 |
103 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.98837091 |
104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97933859 |
105 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97778027 |
106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96843038 |
107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.96233180 |
108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96012755 |
109 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96009971 |
110 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96007261 |
111 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.95416047 |
112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.95191953 |
113 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95139546 |
114 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94540387 |
115 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.94418710 |
116 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94021719 |
117 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93859291 |
118 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93809340 |
119 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93435228 |
120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.92887792 |
121 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91568806 |
122 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91068532 |
123 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90959435 |
124 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90759620 |
125 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89924380 |
126 | * EGR1_19032775_ChIP-ChIP_M12_Human | 0.89763068 |
127 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89349599 |
128 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.89096001 |
129 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88523335 |
130 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.88301103 |
131 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.88262052 |
132 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87875647 |
133 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.87662666 |
134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87642553 |
135 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87197971 |
136 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86888625 |
137 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85637693 |
138 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85043257 |
139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83439603 |
140 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.83344966 |
141 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.82011690 |
142 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81807936 |
143 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.81664332 |
144 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81219201 |
145 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.80924470 |
146 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.79898455 |
147 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79517216 |
148 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79517216 |
149 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79025598 |
150 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78687368 |
151 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.77279020 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 5.55592288 |
2 | MP0003635_abnormal_synaptic_transmissio | 3.35772374 |
3 | MP0004270_analgesia | 3.35728023 |
4 | MP0003880_abnormal_central_pattern | 3.31022093 |
5 | MP0003303_peritoneal_inflammation | 2.83535802 |
6 | MP0002064_seizures | 2.80583682 |
7 | MP0009745_abnormal_behavioral_response | 2.70133383 |
8 | MP0002822_catalepsy | 2.61594931 |
9 | MP0005423_abnormal_somatic_nervous | 2.59799189 |
10 | MP0003690_abnormal_glial_cell | 2.58223206 |
11 | MP0002063_abnormal_learning/memory/cond | 2.55684641 |
12 | MP0001486_abnormal_startle_reflex | 2.54982803 |
13 | MP0009046_muscle_twitch | 2.42799125 |
14 | MP0003329_amyloid_beta_deposits | 2.39260835 |
15 | MP0003724_increased_susceptibility_to | 2.35312186 |
16 | MP0002272_abnormal_nervous_system | 2.32620233 |
17 | MP0004885_abnormal_endolymph | 2.31577777 |
18 | MP0004147_increased_porphyrin_level | 2.20047767 |
19 | MP0002139_abnormal_hepatobiliary_system | 2.11170549 |
20 | MP0002572_abnormal_emotion/affect_behav | 2.07754863 |
21 | MP0009780_abnormal_chondrocyte_physiolo | 2.03685453 |
22 | MP0001501_abnormal_sleep_pattern | 2.00512901 |
23 | MP0008569_lethality_at_weaning | 1.96485060 |
24 | MP0002909_abnormal_adrenal_gland | 1.94031500 |
25 | MP0002734_abnormal_mechanical_nocicepti | 1.93113357 |
26 | MP0000920_abnormal_myelination | 1.88818803 |
27 | MP0003633_abnormal_nervous_system | 1.86063579 |
28 | MP0001968_abnormal_touch/_nociception | 1.79655956 |
29 | MP0009278_abnormal_bone_marrow | 1.75743841 |
30 | MP0004858_abnormal_nervous_system | 1.70161549 |
31 | MP0003656_abnormal_erythrocyte_physiolo | 1.70038552 |
32 | MP0005360_urolithiasis | 1.68696996 |
33 | MP0004130_abnormal_muscle_cell | 1.63920745 |
34 | MP0005167_abnormal_blood-brain_barrier | 1.63738699 |
35 | MP0003075_altered_response_to | 1.63678945 |
36 | MP0005085_abnormal_gallbladder_physiolo | 1.61330296 |
37 | MP0003436_decreased_susceptibility_to | 1.59769796 |
38 | MP0004043_abnormal_pH_regulation | 1.59082324 |
39 | MP0002419_abnormal_innate_immunity | 1.57479216 |
40 | MP0005365_abnormal_bile_salt | 1.55328548 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.54409903 |
42 | MP0001545_abnormal_hematopoietic_system | 1.54409903 |
43 | MP0001440_abnormal_grooming_behavior | 1.52251035 |
44 | MP0005646_abnormal_pituitary_gland | 1.50868030 |
45 | MP0005551_abnormal_eye_electrophysiolog | 1.49265343 |
46 | MP0008260_abnormal_autophagy | 1.48838294 |
47 | MP0010329_abnormal_lipoprotein_level | 1.48793995 |
48 | MP0003631_nervous_system_phenotype | 1.46134672 |
49 | MP0000604_amyloidosis | 1.44234083 |
50 | MP0005464_abnormal_platelet_physiology | 1.43436441 |
51 | MP0002067_abnormal_sensory_capabilities | 1.42530595 |
52 | MP0001970_abnormal_pain_threshold | 1.39426551 |
53 | MP0006082_CNS_inflammation | 1.37610632 |
54 | MP0002090_abnormal_vision | 1.37021469 |
55 | MP0000343_altered_response_to | 1.36164700 |
56 | MP0002733_abnormal_thermal_nociception | 1.35371814 |
57 | MP0008875_abnormal_xenobiotic_pharmacok | 1.34117591 |
58 | MP0003634_abnormal_glial_cell | 1.32573312 |
59 | MP0005535_abnormal_body_temperature | 1.29074235 |
60 | MP0003828_pulmonary_edema | 1.28553177 |
61 | MP0002229_neurodegeneration | 1.26188171 |
62 | MP0000955_abnormal_spinal_cord | 1.24752128 |
63 | MP0005386_behavior/neurological_phenoty | 1.22481032 |
64 | MP0004924_abnormal_behavior | 1.22481032 |
65 | MP0002066_abnormal_motor_capabilities/c | 1.22376814 |
66 | MP0004811_abnormal_neuron_physiology | 1.21589639 |
67 | MP0003300_gastrointestinal_ulcer | 1.20749488 |
68 | MP0002557_abnormal_social/conspecific_i | 1.19732244 |
69 | MP0002132_abnormal_respiratory_system | 1.19085644 |
70 | MP0001853_heart_inflammation | 1.18796762 |
71 | MP0000013_abnormal_adipose_tissue | 1.15017822 |
72 | MP0002118_abnormal_lipid_homeostasis | 1.14706541 |
73 | MP0004142_abnormal_muscle_tone | 1.14186808 |
74 | MP0001502_abnormal_circadian_rhythm | 1.13669410 |
75 | MP0002882_abnormal_neuron_morphology | 1.13484073 |
76 | MP0002736_abnormal_nociception_after | 1.13458336 |
77 | MP0000778_abnormal_nervous_system | 1.07732857 |
78 | MP0008961_abnormal_basal_metabolism | 1.07358048 |
79 | MP0005025_abnormal_response_to | 1.07289192 |
80 | MP0008874_decreased_physiological_sensi | 1.06436552 |
81 | MP0009840_abnormal_foam_cell | 1.04797423 |
82 | MP0003632_abnormal_nervous_system | 1.04713183 |
83 | MP0001177_atelectasis | 1.04536727 |
84 | MP0002998_abnormal_bone_remodeling | 1.03881557 |
85 | MP0001533_abnormal_skeleton_physiology | 1.03730278 |
86 | MP0002133_abnormal_respiratory_system | 1.03314018 |
87 | MP0005388_respiratory_system_phenotype | 1.03314018 |
88 | MP0004883_abnormal_blood_vessel | 1.03144976 |
89 | MP0003879_abnormal_hair_cell | 1.02808883 |
90 | * MP0005332_abnormal_amino_acid | 1.01644514 |
91 | MP0003191_abnormal_cellular_cholesterol | 1.00084324 |
92 | MP0008872_abnormal_physiological_respon | 0.98881163 |
93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98414097 |
94 | MP0003011_delayed_dark_adaptation | 0.95310556 |
95 | MP0003195_calcinosis | 0.95141127 |
96 | MP0005670_abnormal_white_adipose | 0.94432691 |
97 | MP0005666_abnormal_adipose_tissue | 0.93162357 |
98 | MP0003252_abnormal_bile_duct | 0.92722936 |
99 | MP0000751_myopathy | 0.92369198 |
100 | MP0004947_skin_inflammation | 0.91716298 |
101 | MP0001851_eye_inflammation | 0.91626976 |
102 | MP0008004_abnormal_stomach_pH | 0.90448255 |
103 | MP0000747_muscle_weakness | 0.89584030 |
104 | MP0004145_abnormal_muscle_electrophysio | 0.87078702 |
105 | MP0004185_abnormal_adipocyte_glucose | 0.86941308 |
106 | MP0002148_abnormal_hypersensitivity_rea | 0.86318598 |
107 | MP0000681_abnormal_thyroid_gland | 0.86267069 |
108 | MP0005451_abnormal_body_composition | 0.86066119 |
109 | MP0005377_hearing/vestibular/ear_phenot | 0.85978681 |
110 | MP0003878_abnormal_ear_physiology | 0.85978681 |
111 | MP0009764_decreased_sensitivity_to | 0.84903216 |
112 | MP0005000_abnormal_immune_tolerance | 0.83763221 |
113 | * MP0002069_abnormal_eating/drinking_beha | 0.82463996 |
114 | MP0005164_abnormal_response_to | 0.81586557 |
115 | MP0005375_adipose_tissue_phenotype | 0.81265590 |
116 | MP0005058_abnormal_lysosome_morphology | 0.81065767 |
117 | MP0003283_abnormal_digestive_organ | 0.81010794 |
118 | MP0005165_increased_susceptibility_to | 0.80898111 |
119 | MP0003172_abnormal_lysosome_physiology | 0.80615208 |
120 | MP0004085_abnormal_heartbeat | 0.79662756 |
121 | * MP0002152_abnormal_brain_morphology | 0.77553934 |
122 | MP0004215_abnormal_myocardial_fiber | 0.76820926 |
123 | MP0000465_gastrointestinal_hemorrhage | 0.76196639 |
124 | MP0002735_abnormal_chemical_nociception | 0.76052506 |
125 | MP0002184_abnormal_innervation | 0.75953435 |
126 | MP0000003_abnormal_adipose_tissue | 0.75873072 |
127 | MP0001485_abnormal_pinna_reflex | 0.75269897 |
128 | MP0003453_abnormal_keratinocyte_physiol | 0.74340419 |
129 | MP0001984_abnormal_olfaction | 0.74219676 |
130 | MP0001905_abnormal_dopamine_level | 0.73780835 |
131 | MP0002837_dystrophic_cardiac_calcinosis | 0.73309854 |
132 | MP0005253_abnormal_eye_physiology | 0.72496704 |
133 | MP0004510_myositis | 0.71864857 |
134 | MP0005166_decreased_susceptibility_to | 0.71226174 |
135 | MP0003137_abnormal_impulse_conducting | 0.70302034 |
136 | MP0002971_abnormal_brown_adipose | 0.68834987 |
137 | MP0004742_abnormal_vestibular_system | 0.67818025 |
138 | MP0005645_abnormal_hypothalamus_physiol | 0.66687266 |
139 | MP0001790_abnormal_immune_system | 0.65996450 |
140 | MP0005387_immune_system_phenotype | 0.65996450 |
141 | MP0010234_abnormal_vibrissa_follicle | 0.65146117 |
142 | MP0001963_abnormal_hearing_physiology | 0.64057288 |
143 | MP0003705_abnormal_hypodermis_morpholog | 0.63825562 |
144 | MP0005409_darkened_coat_color | 0.63499822 |
145 | MP0009115_abnormal_fat_cell | 0.63158863 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Myokymia (HP:0002411) | 5.68610498 |
2 | Focal motor seizures (HP:0011153) | 5.05041521 |
3 | Action tremor (HP:0002345) | 4.03519948 |
4 | Focal seizures (HP:0007359) | 3.86442501 |
5 | Neurofibrillary tangles (HP:0002185) | 3.72972743 |
6 | Systemic lupus erythematosus (HP:0002725) | 3.62428468 |
7 | Visual hallucinations (HP:0002367) | 3.57178659 |
8 | Supranuclear gaze palsy (HP:0000605) | 3.51570800 |
9 | Intention tremor (HP:0002080) | 3.46955399 |
10 | Ankle clonus (HP:0011448) | 3.38423738 |
11 | Postural instability (HP:0002172) | 3.31452990 |
12 | Eczematoid dermatitis (HP:0000976) | 3.26789304 |
13 | Hemiplegia (HP:0002301) | 3.22030180 |
14 | Increased cerebral lipofuscin (HP:0011813) | 3.13551680 |
15 | Cerebral inclusion bodies (HP:0100314) | 3.07793095 |
16 | Dysdiadochokinesis (HP:0002075) | 3.06972088 |
17 | Dysmetria (HP:0001310) | 3.06502334 |
18 | Megalencephaly (HP:0001355) | 3.06028582 |
19 | Recurrent abscess formation (HP:0002722) | 3.05947879 |
20 | Generalized tonic-clonic seizures (HP:0002069) | 3.03960126 |
21 | Abnormality of glycolipid metabolism (HP:0010969) | 3.03956095 |
22 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.03956095 |
23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.03956095 |
24 | Recurrent bacterial skin infections (HP:0005406) | 2.99772308 |
25 | Glomerulonephritis (HP:0000099) | 2.88506206 |
26 | Depression (HP:0000716) | 2.85092523 |
27 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.83298699 |
28 | Progressive cerebellar ataxia (HP:0002073) | 2.82091561 |
29 | Obstructive sleep apnea (HP:0002870) | 2.77839012 |
30 | Epileptic encephalopathy (HP:0200134) | 2.77592155 |
31 | Abnormal eating behavior (HP:0100738) | 2.71399389 |
32 | Anxiety (HP:0000739) | 2.70718179 |
33 | Hemiparesis (HP:0001269) | 2.70248054 |
34 | Torticollis (HP:0000473) | 2.69715334 |
35 | Amyloidosis (HP:0011034) | 2.67893690 |
36 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.63681727 |
37 | Abnormality of macrophages (HP:0004311) | 2.63208537 |
38 | Impaired social interactions (HP:0000735) | 2.62822061 |
39 | Abnormal social behavior (HP:0012433) | 2.62822061 |
40 | Status epilepticus (HP:0002133) | 2.61559383 |
41 | Poor eye contact (HP:0000817) | 2.57125663 |
42 | Absence seizures (HP:0002121) | 2.53368418 |
43 | Diplopia (HP:0000651) | 2.50621489 |
44 | Abnormality of binocular vision (HP:0011514) | 2.50621489 |
45 | Spastic gait (HP:0002064) | 2.49897021 |
46 | Aplasia of the phalanges of the hand (HP:0009802) | 2.49628541 |
47 | Aplasia involving bones of the extremities (HP:0009825) | 2.49628541 |
48 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.49628541 |
49 | Scanning speech (HP:0002168) | 2.49080093 |
50 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.48615246 |
51 | Complement deficiency (HP:0004431) | 2.44464885 |
52 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.44086017 |
53 | Focal dystonia (HP:0004373) | 2.43544317 |
54 | * Abnormality of the periventricular white matter (HP:0002518) | 2.42722158 |
55 | Urinary urgency (HP:0000012) | 2.42438654 |
56 | Hyperlipoproteinemia (HP:0010980) | 2.42089597 |
57 | Dialeptic seizures (HP:0011146) | 2.39398771 |
58 | Slow saccadic eye movements (HP:0000514) | 2.38925431 |
59 | Increased circulating renin level (HP:0000848) | 2.36177796 |
60 | Truncal ataxia (HP:0002078) | 2.32723108 |
61 | Deep venous thrombosis (HP:0002625) | 2.32499964 |
62 | Apathy (HP:0000741) | 2.30877726 |
63 | Papilledema (HP:0001085) | 2.30185019 |
64 | Xanthomatosis (HP:0000991) | 2.29512289 |
65 | Atonic seizures (HP:0010819) | 2.29427699 |
66 | Ventricular fibrillation (HP:0001663) | 2.29267993 |
67 | Bowel incontinence (HP:0002607) | 2.29084637 |
68 | Onion bulb formation (HP:0003383) | 2.28936786 |
69 | Delusions (HP:0000746) | 2.28220192 |
70 | Craniofacial dystonia (HP:0012179) | 2.27941687 |
71 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27790849 |
72 | Abnormal large intestine physiology (HP:0012700) | 2.26420033 |
73 | Abnormality of glycine metabolism (HP:0010895) | 2.25181358 |
74 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.25181358 |
75 | Bundle branch block (HP:0011710) | 2.25121332 |
76 | Mutism (HP:0002300) | 2.24018618 |
77 | Peripheral hypomyelination (HP:0007182) | 2.22450203 |
78 | Tetraplegia (HP:0002445) | 2.21217640 |
79 | Purpura (HP:0000979) | 2.21205572 |
80 | Interstitial pulmonary disease (HP:0006530) | 2.18781386 |
81 | Gaze-evoked nystagmus (HP:0000640) | 2.17063255 |
82 | Abnormality of the lower motor neuron (HP:0002366) | 2.15592965 |
83 | Clonus (HP:0002169) | 2.15329188 |
84 | Broad-based gait (HP:0002136) | 2.14972493 |
85 | Confusion (HP:0001289) | 2.14677819 |
86 | Memory impairment (HP:0002354) | 2.14044880 |
87 | Dementia (HP:0000726) | 2.13860449 |
88 | Rigidity (HP:0002063) | 2.13131729 |
89 | Bradykinesia (HP:0002067) | 2.13097049 |
90 | Diminished motivation (HP:0000745) | 2.12847600 |
91 | Termporal pattern (HP:0011008) | 2.11493628 |
92 | Insidious onset (HP:0003587) | 2.11493628 |
93 | Polycythemia (HP:0001901) | 2.10967772 |
94 | Spastic tetraparesis (HP:0001285) | 2.10735642 |
95 | Febrile seizures (HP:0002373) | 2.10017473 |
96 | Lower limb muscle weakness (HP:0007340) | 2.09251560 |
97 | Pheochromocytoma (HP:0002666) | 2.08904379 |
98 | Disinhibition (HP:0000734) | 2.08455126 |
99 | Neuronal loss in central nervous system (HP:0002529) | 2.06468145 |
100 | Hyperglycinuria (HP:0003108) | 2.04860521 |
101 | Ketosis (HP:0001946) | 2.04839641 |
102 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.03955265 |
103 | Muscle fiber splitting (HP:0003555) | 2.03479053 |
104 | Dysmetric saccades (HP:0000641) | 2.03425570 |
105 | Hyperventilation (HP:0002883) | 2.02889669 |
106 | Retinal atrophy (HP:0001105) | 2.02548980 |
107 | Cellulitis (HP:0100658) | 2.01943226 |
108 | Abnormality of the corticospinal tract (HP:0002492) | 2.01915718 |
109 | Metabolic alkalosis (HP:0200114) | 2.01399561 |
110 | Myositis (HP:0100614) | 2.01213618 |
111 | Intrahepatic cholestasis (HP:0001406) | 1.98836715 |
112 | Clumsiness (HP:0002312) | 1.97624861 |
113 | Orchitis (HP:0100796) | 1.97407177 |
114 | Abnormality of saccadic eye movements (HP:0000570) | 1.97278523 |
115 | Impaired vibratory sensation (HP:0002495) | 1.97061675 |
116 | Cholecystitis (HP:0001082) | 1.96550604 |
117 | Abnormal gallbladder physiology (HP:0012438) | 1.96550604 |
118 | Abnormality of complement system (HP:0005339) | 1.95890832 |
119 | Vertigo (HP:0002321) | 1.95459591 |
120 | Annular pancreas (HP:0001734) | 1.95177579 |
121 | Dysostosis multiplex (HP:0000943) | 1.95084315 |
122 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.94319578 |
123 | Decreased motor nerve conduction velocity (HP:0003431) | 1.93318981 |
124 | Turricephaly (HP:0000262) | 1.92949299 |
125 | Genetic anticipation (HP:0003743) | 1.92782236 |
126 | Hyperglycinemia (HP:0002154) | 1.92422454 |
127 | Lower limb asymmetry (HP:0100559) | 1.92243115 |
128 | Choreoathetosis (HP:0001266) | 1.92116419 |
129 | Loss of speech (HP:0002371) | 1.91234522 |
130 | Ketoacidosis (HP:0001993) | 1.90795712 |
131 | Retrobulbar optic neuritis (HP:0100654) | 1.90024738 |
132 | Optic neuritis (HP:0100653) | 1.90024738 |
133 | Myocardial infarction (HP:0001658) | 1.89625396 |
134 | Exercise-induced myalgia (HP:0003738) | 1.89593536 |
135 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.88533287 |
136 | Personality changes (HP:0000751) | 1.87532697 |
137 | Increased CSF protein (HP:0002922) | 1.86589701 |
138 | Insomnia (HP:0100785) | 1.86547128 |
139 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.86234042 |
140 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.86234042 |
141 | Postural tremor (HP:0002174) | 1.85741769 |
142 | Mediastinal lymphadenopathy (HP:0100721) | 1.85229911 |
143 | Axonal loss (HP:0003447) | 1.84494480 |
144 | Abnormality of the Achilles tendon (HP:0005109) | 1.83865312 |
145 | Generalized myoclonic seizures (HP:0002123) | 1.83578972 |
146 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.82975109 |
147 | Absent/shortened dynein arms (HP:0200106) | 1.82975109 |
148 | Foot dorsiflexor weakness (HP:0009027) | 1.82167602 |
149 | Rapidly progressive (HP:0003678) | 1.82156844 |
150 | Central scotoma (HP:0000603) | 1.81867803 |
151 | Global brain atrophy (HP:0002283) | 1.80114607 |
152 | Gait ataxia (HP:0002066) | 1.79785132 |
153 | Gingivitis (HP:0000230) | 1.79471321 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 3.88658852 |
2 | PRKD3 | 3.14457315 |
3 | NTRK3 | 3.04876090 |
4 | MAP3K9 | 3.00416671 |
5 | DAPK2 | 2.48631573 |
6 | PAK6 | 2.27322148 |
7 | KSR2 | 2.21568215 |
8 | MAP3K4 | 2.08142734 |
9 | NTRK1 | 2.04809004 |
10 | CAMKK1 | 2.04487203 |
11 | NTRK2 | 1.99838299 |
12 | MINK1 | 1.86482792 |
13 | PINK1 | 1.81138080 |
14 | TRIB3 | 1.79362202 |
15 | BLK | 1.71897903 |
16 | MATK | 1.68878553 |
17 | MAP2K4 | 1.67258236 |
18 | SGK223 | 1.66913181 |
19 | SGK494 | 1.66913181 |
20 | LMTK2 | 1.58984380 |
21 | CAMK1G | 1.58615502 |
22 | STK38 | 1.55688536 |
23 | BMPR2 | 1.55021811 |
24 | JAK2 | 1.54307634 |
25 | OXSR1 | 1.54085136 |
26 | MARK1 | 1.53080841 |
27 | FGFR2 | 1.47037890 |
28 | TYRO3 | 1.46606002 |
29 | PHKG2 | 1.44670903 |
30 | PHKG1 | 1.44670903 |
31 | STK39 | 1.43298202 |
32 | MAP3K2 | 1.41573157 |
33 | CDK5 | 1.40716650 |
34 | TYK2 | 1.29012539 |
35 | PRKCH | 1.26115143 |
36 | RIPK1 | 1.22060183 |
37 | MAPK15 | 1.20912888 |
38 | MAP2K7 | 1.19659876 |
39 | SGK3 | 1.17409345 |
40 | PDPK1 | 1.16798046 |
41 | CAMK1D | 1.13533242 |
42 | RAF1 | 1.04660678 |
43 | PDK1 | 1.04633747 |
44 | STK11 | 1.03739327 |
45 | UHMK1 | 1.03479410 |
46 | MAP3K13 | 1.03031221 |
47 | LATS2 | 1.02727961 |
48 | JAK1 | 1.02024988 |
49 | CAMK1 | 1.01451265 |
50 | RET | 1.00753647 |
51 | CSK | 1.00490414 |
52 | ZAP70 | 1.00455317 |
53 | SGK2 | 1.00311271 |
54 | WNK1 | 0.96954488 |
55 | GRK5 | 0.96943616 |
56 | RIPK4 | 0.92538453 |
57 | CAMKK2 | 0.92509198 |
58 | MAPKAPK5 | 0.91051169 |
59 | DYRK1A | 0.90197800 |
60 | MAP3K11 | 0.89953743 |
61 | DMPK | 0.88452125 |
62 | PKN1 | 0.88092348 |
63 | TAOK1 | 0.87627646 |
64 | CDK19 | 0.86355030 |
65 | PRKCG | 0.86175241 |
66 | CAMK2B | 0.85382338 |
67 | KSR1 | 0.85110385 |
68 | MAP3K7 | 0.84332179 |
69 | PNCK | 0.83583274 |
70 | FES | 0.83383142 |
71 | ALK | 0.82797777 |
72 | FGR | 0.81865830 |
73 | CAMK2G | 0.81069511 |
74 | PAK3 | 0.79317190 |
75 | KIT | 0.79292545 |
76 | MAPK10 | 0.74560767 |
77 | PRKD1 | 0.74543860 |
78 | CAMK2A | 0.74094257 |
79 | SIK1 | 0.73455674 |
80 | FGFR3 | 0.73158353 |
81 | WNK4 | 0.71441676 |
82 | NEK6 | 0.71286364 |
83 | SGK1 | 0.70555735 |
84 | MAP3K1 | 0.69247377 |
85 | EPHA3 | 0.69140569 |
86 | JAK3 | 0.67674607 |
87 | ERBB2 | 0.67071178 |
88 | MARK2 | 0.67022140 |
89 | SYK | 0.65624231 |
90 | IRAK2 | 0.64942938 |
91 | BCKDK | 0.64525142 |
92 | CAMK2D | 0.64493076 |
93 | ARAF | 0.63786580 |
94 | ERN1 | 0.63711283 |
95 | PRPF4B | 0.63630843 |
96 | TNIK | 0.63585933 |
97 | CDK15 | 0.62581111 |
98 | FGFR4 | 0.62071233 |
99 | CDK14 | 0.61780153 |
100 | SIK2 | 0.60685355 |
101 | CAMK4 | 0.60256989 |
102 | MAP2K3 | 0.60241413 |
103 | MAPK12 | 0.59923716 |
104 | EPHB1 | 0.59150978 |
105 | DAPK1 | 0.59131402 |
106 | PDK2 | 0.59066960 |
107 | RPS6KA3 | 0.58999902 |
108 | CDK18 | 0.58054189 |
109 | MAP3K14 | 0.57603217 |
110 | CSNK1G2 | 0.56810555 |
111 | MAPK4 | 0.56460714 |
112 | PRKCZ | 0.56075493 |
113 | PDGFRA | 0.54114937 |
114 | MAPK7 | 0.53495654 |
115 | PTK2B | 0.53214357 |
116 | TNK2 | 0.53088043 |
117 | TBK1 | 0.51070128 |
118 | HCK | 0.50804089 |
119 | PLK2 | 0.50592572 |
120 | ROCK2 | 0.50511799 |
121 | DAPK3 | 0.50128854 |
122 | MUSK | 0.50004850 |
123 | CDK11A | 0.49444589 |
124 | MOS | 0.49285507 |
125 | CDC42BPA | 0.48544347 |
126 | FYN | 0.48364482 |
127 | MAP3K6 | 0.46952696 |
128 | BMX | 0.46445386 |
129 | PRKACG | 0.45542260 |
130 | INSRR | 0.44947022 |
131 | MAPK13 | 0.44649750 |
132 | ICK | 0.44298606 |
133 | MAP2K1 | 0.42724758 |
134 | MAP3K3 | 0.42694796 |
135 | TAOK2 | 0.39572656 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Nitrogen metabolism_Homo sapiens_hsa00910 | 3.05238297 |
2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.37738754 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.04302959 |
4 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.99991852 |
5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.89910607 |
6 | Nicotine addiction_Homo sapiens_hsa05033 | 1.86213977 |
7 | Olfactory transduction_Homo sapiens_hsa04740 | 1.86178392 |
8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.81461214 |
9 | Circadian entrainment_Homo sapiens_hsa04713 | 1.78048752 |
10 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 1.77461932 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 1.73051153 |
12 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.67245483 |
13 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.66550602 |
14 | Morphine addiction_Homo sapiens_hsa05032 | 1.63932208 |
15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.62989049 |
16 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.59628949 |
17 | Insulin secretion_Homo sapiens_hsa04911 | 1.57017971 |
18 | Bile secretion_Homo sapiens_hsa04976 | 1.55510175 |
19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.54938598 |
20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.54685082 |
21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53918777 |
22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53578559 |
23 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.52678728 |
24 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.50252816 |
25 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.47513873 |
26 | * Arginine biosynthesis_Homo sapiens_hsa00220 | 1.43342413 |
27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.42933948 |
28 | Lysosome_Homo sapiens_hsa04142 | 1.41703726 |
29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.41484646 |
30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.38308945 |
31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.35166719 |
32 | * Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.34264085 |
33 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.28579866 |
34 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.28340728 |
35 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27266832 |
36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.27157220 |
37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.27071940 |
38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.25987727 |
39 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.25529416 |
40 | Renin secretion_Homo sapiens_hsa04924 | 1.19914749 |
41 | Tuberculosis_Homo sapiens_hsa05152 | 1.19894525 |
42 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.18225393 |
43 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.17087046 |
44 | Cocaine addiction_Homo sapiens_hsa05030 | 1.16003040 |
45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.14807922 |
46 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12063425 |
47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12036467 |
48 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.11656213 |
49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.05890724 |
50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04229143 |
51 | Pertussis_Homo sapiens_hsa05133 | 1.02888417 |
52 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.02732399 |
53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01303400 |
54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.01229040 |
55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98723218 |
56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97765474 |
57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94729022 |
58 | Phagosome_Homo sapiens_hsa04145 | 0.94289729 |
59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.93212555 |
60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93113516 |
61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.92921471 |
62 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92059617 |
63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91919175 |
64 | Phototransduction_Homo sapiens_hsa04744 | 0.91399866 |
65 | Long-term depression_Homo sapiens_hsa04730 | 0.91387483 |
66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.89526717 |
67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89517844 |
68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87021501 |
69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86181437 |
70 | Mineral absorption_Homo sapiens_hsa04978 | 0.84900119 |
71 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84075406 |
72 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.83928285 |
73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82298587 |
74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81839928 |
75 | Gap junction_Homo sapiens_hsa04540 | 0.79580548 |
76 | Taste transduction_Homo sapiens_hsa04742 | 0.79146491 |
77 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.78869709 |
78 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.78578984 |
79 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77287737 |
80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76170193 |
81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.75415178 |
82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75400515 |
83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75382089 |
84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74449868 |
85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74375887 |
86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.73890228 |
87 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73612572 |
88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73383243 |
89 | Malaria_Homo sapiens_hsa05144 | 0.73040654 |
90 | * Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72989721 |
91 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72265886 |
92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.71604458 |
93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71492879 |
94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71345538 |
95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70988381 |
96 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69973592 |
97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.68404241 |
98 | Glioma_Homo sapiens_hsa05214 | 0.67905920 |
99 | Prion diseases_Homo sapiens_hsa05020 | 0.67567628 |
100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.65533749 |
101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.65453258 |
102 | Legionellosis_Homo sapiens_hsa05134 | 0.65238636 |
103 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64035760 |
104 | Platelet activation_Homo sapiens_hsa04611 | 0.63806384 |
105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63469582 |
106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63257029 |
107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62818681 |
108 | Amoebiasis_Homo sapiens_hsa05146 | 0.62737081 |
109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61627420 |
110 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61445820 |
111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61153631 |
112 | Melanogenesis_Homo sapiens_hsa04916 | 0.60763565 |
113 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60689253 |
114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.58628364 |
115 | Peroxisome_Homo sapiens_hsa04146 | 0.57421826 |
116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57212999 |
117 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56991915 |
118 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56517377 |
119 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56166412 |
120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54599531 |
121 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.51528582 |
122 | ABC transporters_Homo sapiens_hsa02010 | 0.50763087 |
123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50285998 |
124 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50229714 |
125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49746490 |
126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49019731 |
127 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48705288 |
128 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.48284154 |
129 | Salmonella infection_Homo sapiens_hsa05132 | 0.48163691 |
130 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46602443 |
131 | Endocytosis_Homo sapiens_hsa04144 | 0.45212562 |
132 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43769782 |
133 | Axon guidance_Homo sapiens_hsa04360 | 0.43720442 |
134 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42825765 |
135 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42490053 |
136 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.41492204 |
137 | Insulin resistance_Homo sapiens_hsa04931 | 0.41242477 |
138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40926671 |
139 | Histidine metabolism_Homo sapiens_hsa00340 | 0.40779172 |
140 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.40735914 |
141 | Circadian rhythm_Homo sapiens_hsa04710 | 0.39711373 |
142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.38917946 |
143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38796154 |